+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
C-Reactive Protein Testing Market by Assay Type, Disease Area, Detection Range, End-User - Global Forecast 2025-2030- Product Image
C-Reactive Protein Testing Market by Assay Type, Disease Area, Detection Range, End-User - Global Forecast 2025-2030- Product Image
Sale

C-Reactive Protein Testing Market by Assay Type, Disease Area, Detection Range, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6011545
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The C-Reactive Protein Testing Market grew from USD 1.50 billion in 2023 to USD 1.69 billion in 2024. It is expected to continue growing at a CAGR of 12.41%, reaching USD 3.42 billion by 2030.

C-Reactive Protein (CRP) testing is a diagnostic tool used to assess inflammation levels in the body, typically aiding in the detection and monitoring of conditions like infections, inflammatory diseases, and cardiovascular diseases. The necessity of CRP testing stems from its ability to provide early warnings of diseases, allowing for timely medical interventions. It finds application in various clinical settings, including hospitals, laboratories, and homecare diagnostics, with end-use primarily revolving around healthcare providers, research organizations, and diagnostic centers. The market for CRP testing is fueled by growing awareness about health and wellness, increasing incidences of chronic disorders, and technological advancements in diagnostic technology like high-sensitivity assays. Additionally, the trend towards preventive healthcare and personalized medicine drives the demand for more precise and less invasive diagnostic options, further bolstering CRP testing utilization. Key opportunities lie in expanding applications in cardiovascular and metabolic disease monitoring, along with the development of point-of-care testing devices that offer rapid results. Nonetheless, market growth faces challenges in the form of high costs associated with advanced testing systems, regulatory hurdles, and competition from alternative diagnostic methods. To address these challenges and seize opportunities, innovation could focus on enhancing the sensitivity and specificity of assays, investing in cost-effective portable testing solutions, and developing integrated health monitoring systems that collaborate with wearable technologies. Market players could also benefit from partnering with technology firms to leverage AI and data analytics in predictive diagnostics, opening new pathways for proactive healthcare management. Ultimately, continuous R&D investments to address technological limitations and adapting to evolving regulatory frameworks will be crucial, as the market is characterized by rapid technological advancements and competitive pressures, requiring nimbleness in response to shifting healthcare paradigms and consumer expectations.

Understanding Market Dynamics in the C-Reactive Protein Testing Market

The C-Reactive Protein Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Need to measure inflammation caused by a wide variety of health conditions
    • Rising incidence of chronic disorders and growing geriatric population
    • Improvements in C-reactive protein point-of-care testing for safely reducing antibiotic
  • Market Restraints
    • Issues associated with efficacy and specificity of C-Reactive protein testing
  • Market Opportunities
    • Technological advancements pertaining to conventional CRP tests
    • Research on C‐reactive protein in gastrointestinal diseases of dogs
  • Market Challenges
    • Stringent approval processes for testing techniques and products

Exploring Porter’s Five Forces for the C-Reactive Protein Testing Market

Porter’s Five Forces framework further strengthens the insights of the C-Reactive Protein Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the C-Reactive Protein Testing Market

External macro-environmental factors deeply influence the performance of the C-Reactive Protein Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the C-Reactive Protein Testing Market

The C-Reactive Protein Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the C-Reactive Protein Testing Market

The C-Reactive Protein Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the C-Reactive Protein Testing Market

The C-Reactive Protein Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the C-Reactive Protein Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam PLC, Alere Inc., BIOMÉRIEUX, BODITECH MED, Inc., CTK Biotech Inc., Danaher Corporation, DiaSorin S.p.A., Eurolyser Diagnostica GmbH, F. Hoffmann-La Roche Ltd., Fujifilm Corporation, Getein Biotech, Inc., HORIBA, Ltd., Laboratory Corporation of America Holdings (LabCorp), Lumiradx Healthcare Private Limited, Merck KGaA, Ortho Clinical Diagnostics, Quest Diagnostics Incorporated, Randox Laboratories Ltd., SD Biosensor, Inc., Sekisui Diagnostics, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the C-Reactive Protein Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Assay Type
    • Chemiluminescence Immunoassay
      • Free T3
      • Free T4
      • Thyrotropin Levels
    • ELISA
      • Clinical
      • Nonclinical
    • Immunoturbidimetric Assay
    • Radioimmunoassay
      • Autoantibodies Against Thyrotropin Receptor
      • Human Serum Thyroglobulin Autoantibodies
      • Thyroperoxidase Autoantibodies
  • Disease Area
    • Cancer
    • Cardiovascular Diseases
    • Endometriosis
    • Inflammatory Bowel Disease
    • Lupus
    • Rheumatoid Arthritis
  • Detection Range
    • cCRP
    • Conventional CRP
    • hs-CRP
  • End-User
    • Assisted Living Healthcare Facilities
    • Clinics
    • Hospitals
    • Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need to measure inflammation caused by a wide variety of health conditions
5.1.1.2. Rising incidence of chronic disorders and growing geriatric population
5.1.1.3. Improvements in C-reactive protein point-of-care testing for safely reducing antibiotic
5.1.2. Restraints
5.1.2.1. Issues associated with efficacy and specificity of C-Reactive protein testing
5.1.3. Opportunities
5.1.3.1. Technological advancements pertaining to conventional CRP tests
5.1.3.2. Research on C-reactive protein in gastrointestinal diseases of dogs
5.1.4. Challenges
5.1.4.1. Stringent approval processes for testing techniques and products
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. C-Reactive Protein Testing Market, by Assay Type
6.1. Introduction
6.2. Chemiluminescence Immunoassay
6.2.1. Free T3
6.2.2. Free T4
6.2.3. Thyrotropin Levels
6.3. ELISA
6.3.1. Clinical
6.3.2. Nonclinical
6.4. Immunoturbidimetric Assay
6.5. Radioimmunoassay
6.5.1. Autoantibodies Against Thyrotropin Receptor
6.5.2. Human Serum Thyroglobulin Autoantibodies
6.5.3. Thyroperoxidase Autoantibodies
7. C-Reactive Protein Testing Market, by Disease Area
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Diseases
7.4. Endometriosis
7.5. Inflammatory Bowel Disease
7.6. Lupus
7.7. Rheumatoid Arthritis
8. C-Reactive Protein Testing Market, by Detection Range
8.1. Introduction
8.2. cCRP
8.3. Conventional CRP
8.4. hs-CRP
9. C-Reactive Protein Testing Market, by End-User
9.1. Introduction
9.2. Assisted Living Healthcare Facilities
9.3. Clinics
9.4. Hospitals
9.5. Laboratories
10. Americas C-Reactive Protein Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific C-Reactive Protein Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa C-Reactive Protein Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. C-REACTIVE PROTEIN TESTING MARKET RESEARCH PROCESS
FIGURE 2. C-REACTIVE PROTEIN TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2023 VS 2030 (%)
FIGURE 9. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. C-REACTIVE PROTEIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. C-REACTIVE PROTEIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. C-REACTIVE PROTEIN TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. C-REACTIVE PROTEIN TESTING MARKET DYNAMICS
TABLE 7. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T3, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY FREE T4, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROTROPIN LEVELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY NONCLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY IMMUNOTURBIDIMETRIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY AUTOANTIBODIES AGAINST THYROTROPIN RECEPTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HUMAN SERUM THYROGLOBULIN AUTOANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY THYROPEROXIDASE AUTOANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LUPUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CCRP, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CONVENTIONAL CRP, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSISTED LIVING HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 62. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 63. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 64. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 65. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 66. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 67. CANADA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 69. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 70. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 71. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 72. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 73. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 99. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 100. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 101. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 102. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 103. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 104. CHINA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 106. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 107. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 108. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 109. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 110. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 111. INDIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 120. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 121. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 122. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 123. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 124. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 125. JAPAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 146. SINGAPORE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 152. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 153. SOUTH KOREA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 159. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 160. TAIWAN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 162. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 163. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 164. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 165. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 166. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 167. THAILAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 173. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 174. VIETNAM C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 183. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 184. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 185. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 186. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 187. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 188. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 189. DENMARK C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 191. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 192. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 193. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 194. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 195. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 196. EGYPT C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 198. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 199. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 200. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 201. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 202. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 203. FINLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 205. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 206. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 207. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 208. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 209. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 210. FRANCE C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 212. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 213. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 214. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 215. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 216. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 217. GERMANY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 223. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 224. ISRAEL C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 226. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 227. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 228. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 229. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 230. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 231. ITALY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 247. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 248. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 249. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 250. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 251. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 252. NORWAY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 254. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 255. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 256. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 257. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 258. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 259. POLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 261. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 262. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 263. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 264. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 265. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 266. QATAR C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 289. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 290. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 291. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 292. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 293. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 294. SPAIN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 307. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 308. SWITZERLAND C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 309. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 310. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 311. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 312. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 313. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DISEASE AREA, 2018-2030 (USD MILLION)
TABLE 314. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY DETECTION RANGE, 2018-2030 (USD MILLION)
TABLE 315. TURKEY C-REACTIVE PROTEIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES C-REACTIVE PROTEIN TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES C-REACTIVE PROTEIN T

Companies Mentioned

The leading players in the C-Reactive Protein Testing market, which are profiled in this report, include:
  • Abbott Laboratories
  • Abcam PLC
  • Alere Inc.
  • BIOMÉRIEUX
  • BODITECH MED, Inc.
  • CTK Biotech Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eurolyser Diagnostica GmbH
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Corporation
  • Getein Biotech, Inc.
  • HORIBA, Ltd.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Lumiradx Healthcare Private Limited
  • Merck KGaA
  • Ortho Clinical Diagnostics
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • SD Biosensor, Inc.
  • Sekisui Diagnostics
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC
  • Zoetis Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.42 Billion
Compound Annual Growth Rate12.4%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

C-Reactive Protein Testing Global Market Report 2024 - Product Image

C-Reactive Protein Testing Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
C Reactive Protein Testing Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

C Reactive Protein Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
C-Reactive Protein Testing - Global Strategic Business Report - Product Image

C-Reactive Protein Testing - Global Strategic Business Report

  • Report
  • 244 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test, By Technology, By Application, By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test, By Technology, By Application, By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
C-Reactive Protein (CRP) Testing Market - Forecasts from 2024 to 2029 - Product Image

C-Reactive Protein (CRP) Testing Market - Forecasts from 2024 to 2029

  • Report
  • 124 Pages
  • Global
From

About the C Reactive Protein Test Market

The C Reactive Protein Test is a type of In Vitro Diagnostics (IVD) test used to detect inflammation in the body. It is a blood test that measures the amount of C-reactive protein (CRP) in the blood. CRP is a protein produced by the liver in response to inflammation. High levels of CRP in the blood can indicate an infection or other inflammatory condition. The C Reactive Protein Test is used to diagnose and monitor a variety of conditions, including rheumatoid arthritis, lupus, and inflammatory bowel disease. It is also used to monitor the effectiveness of treatments for these conditions. The C Reactive Protein Test market is a growing segment of the IVD market. It is used in both clinical and research settings, and is becoming increasingly popular due to its accuracy and ease of use. Companies in the C Reactive Protein Test market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.